J.C. Ahomadegbe

532 total citations
8 papers, 454 citations indexed

About

J.C. Ahomadegbe is a scholar working on Oncology, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, J.C. Ahomadegbe has authored 8 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 2 papers in Otorhinolaryngology. Recurrent topics in J.C. Ahomadegbe's work include Cancer-related Molecular Pathways (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Head and Neck Cancer Studies (2 papers). J.C. Ahomadegbe is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Head and Neck Cancer Studies (2 papers). J.C. Ahomadegbe collaborates with scholars based in France. J.C. Ahomadegbe's co-authors include Michel Barrois, Sandy Fogel, Sétha Douc‐Rasy, G Riou, Pierre Duvillard, P. Armand, D. Stéhelin, Jean Coll, Gaëtan Riou and Sophie Tourpin and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Oncogene and Current Medicinal Chemistry.

In The Last Decade

J.C. Ahomadegbe

8 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.C. Ahomadegbe France 7 260 246 140 86 74 8 454
François Waridel Switzerland 7 212 0.8× 162 0.7× 68 0.5× 63 0.7× 20 0.3× 18 343
Eiki Sakai Japan 7 243 0.9× 187 0.8× 71 0.5× 95 1.1× 36 0.5× 13 401
Pankaj Pande India 9 194 0.7× 144 0.6× 96 0.7× 72 0.8× 20 0.3× 20 361
M. H. Ng Hong Kong 10 213 0.8× 91 0.4× 72 0.5× 92 1.1× 8 0.1× 13 366
Yuuji Nakahara Japan 12 278 1.1× 355 1.4× 94 0.7× 86 1.0× 23 0.3× 14 534
Samantha Leung United States 5 251 1.0× 160 0.7× 54 0.4× 39 0.5× 25 0.3× 6 412
D.N. Dokianakis Greece 10 303 1.2× 230 0.9× 89 0.6× 21 0.2× 41 0.6× 12 468
Eline J. C. Nieuwenhuis Netherlands 10 258 1.0× 184 0.7× 100 0.7× 268 3.1× 23 0.3× 11 514
Carolien Boeckx Belgium 12 225 0.9× 155 0.6× 99 0.7× 35 0.4× 7 0.1× 15 374
Christian Lussier Canada 10 122 0.5× 206 0.8× 65 0.5× 13 0.2× 19 0.3× 16 408

Countries citing papers authored by J.C. Ahomadegbe

Since Specialization
Citations

This map shows the geographic impact of J.C. Ahomadegbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.C. Ahomadegbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.C. Ahomadegbe more than expected).

Fields of papers citing papers by J.C. Ahomadegbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.C. Ahomadegbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.C. Ahomadegbe. The network helps show where J.C. Ahomadegbe may publish in the future.

Co-authorship network of co-authors of J.C. Ahomadegbe

This figure shows the co-authorship network connecting the top 25 collaborators of J.C. Ahomadegbe. A scholar is included among the top collaborators of J.C. Ahomadegbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.C. Ahomadegbe. J.C. Ahomadegbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Alsafadi, Samar, Sophie Tourpin, Fabrice André, Gilles Vassal, & J.C. Ahomadegbe. (2009). P53 Family: At the Crossroads in Cancer Therapy. Current Medicinal Chemistry. 16(32). 4328–4344. 25 indexed citations
2.
Bertucci, François, Béatrice Orsetti, Vincent Nègre, et al.. (2008). Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. Oncogene. 27(40). 5359–5372. 86 indexed citations
3.
Ahomadegbe, J.C., Sophie Tourpin, Mourad Kaghad, et al.. (2000). Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: Prevalence of alterations in inflammatory breast cancers. Oncogene. 19(47). 5413–5418. 44 indexed citations
4.
Bénard, Jean & J.C. Ahomadegbe. (1997). [TSG101 and breast cancer: a correctly named tumor-suppressor gene?].. PubMed. 84(12). 1141–2. 1 indexed citations
5.
Ahomadegbe, J.C., et al.. (1996). [High incidence of p53 mutations in primary and metastatic head and neck tumors. Frequent protein overexpression in normal epithelium].. PubMed. 83(3). 227–33. 7 indexed citations
6.
Douc‐Rasy, Sétha, Michel Barrois, Sandy Fogel, et al.. (1996). High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.. PubMed. 12(2). 423–30. 99 indexed citations
7.
Ahomadegbe, J.C., Michel Barrois, Sandy Fogel, et al.. (1995). High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.. PubMed. 10(6). 1217–27. 176 indexed citations
8.
Zhou, D-C, et al.. (1990). Expression of Multidrug-Resistance (MDR1) Gene in Normal Epithelia and in Invasive Carcinomas of the Uterine Cervix. JNCI Journal of the National Cancer Institute. 82(18). 1493–1496. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026